Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Bought by Stephens Inc. AR

Stephens Inc. AR grew its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 25.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,627 shares of the company’s stock after buying an additional 1,134 shares during the quarter. Stephens Inc. AR’s holdings in Acadia Healthcare were worth $223,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Blue Trust Inc. boosted its stake in shares of Acadia Healthcare by 69.4% during the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock valued at $33,000 after buying an additional 345 shares during the last quarter. Nisa Investment Advisors LLC boosted its stake in shares of Acadia Healthcare by 40.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock valued at $41,000 after buying an additional 301 shares during the last quarter. Fifth Third Bancorp boosted its stake in shares of Acadia Healthcare by 56.0% during the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock valued at $50,000 after buying an additional 454 shares during the last quarter. Covestor Ltd boosted its stake in shares of Acadia Healthcare by 834.4% during the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company’s stock valued at $72,000 after buying an additional 1,018 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale purchased a new position in shares of Acadia Healthcare during the 3rd quarter valued at approximately $86,000.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on ACHC shares. Barclays reduced their price objective on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research note on Friday, November 22nd. TD Cowen reduced their price objective on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a research note on Tuesday, January 7th. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and raised their price objective for the stock from $45.00 to $75.00 in a research note on Thursday, December 12th. Cantor Fitzgerald restated a “neutral” rating and set a $52.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Finally, KeyCorp upgraded Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 price objective on the stock in a research note on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $70.22.

Acadia Healthcare Price Performance

Shares of ACHC opened at $41.06 on Monday. The firm has a market capitalization of $3.81 billion, a price-to-earnings ratio of 13.46, a price-to-earnings-growth ratio of 1.75 and a beta of 1.30. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. Acadia Healthcare Company, Inc. has a one year low of $36.50 and a one year high of $87.77. The stock’s fifty day moving average is $42.09 and its 200-day moving average is $53.90.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.